Now showing items 21-26 of 26
Who smokes in Europe? Data from 12 european countriesin the TackSHS survey (2017–2018)
(Journal of Epidemiology, 2021)
Background: Population data on tobacco use and its determinants require continuous monitoring and careful inter-country comparison. We aimed to provide the most up-to-date estimates on tobacco smoking ...
Estimates of costs for modelling return on investment from smoking cessation interventions
Background and aims: Modelling return on investment (ROI) from smoking cessation interventions requires estimates of their costs and benefits. This paper describes a standardized method developed to ...
Analysis of three strategies to increase screening coverage for cervical cancer in the general population of women aged 60 to 70 years: the CRICERVA study
(BMC Women's Health, 2014-07-16)
Background: Cervical cancer is a frequently diagnosed cancer in women worldwide. Despite having easy preventive and therapeutic approaches, it is an important cause of mortality among women. Methods: ...
Understanding perceived availability and importance of tobacco control interventions to inform European adoption of a UK economic model: a cross-sectional study
(BMC Health Services Research, 2018-02-14)
Background: The evidence on the extent to which stakeholders in different European countries agree with availability and importance of tobacco-control interventions is limited. This study assessed and ...
Increasing Cervical Cancer Screening Coverage: A Randomised, Community-Based Clinical Trial
(PLoS One, 2017-01-24)
Background: Opportunistic cervical cancer screening can lead to suboptimal screening coverage. Coverage could be increased after a personalised invitation to the target population. We present a community ...
Economic evaluation of three populational screening strategies for cervical cancer in the county of Valles Occidental: CRICERVA clinical trial
(BMC Health Services Research, 2011-10-19)
Background: A high percentage of cervical cancer cases have not undergone cytological tests within 10 years prior to diagnosis. Different population interventions could improve coverage in the public ...